Eight of the TSX's 10 sectors were higher

Some people, oblivious of Rua's years in Pride, had claimed that Rua had absolutely no chance to win and didn't even deserve to be in the cage with Machida in the first place.It's funny how a well-executed, solid game plan can turn the MMA world upside down, isn't itThe sport is now in a slight daze as the "unbeatable" champion had shown that he has flawsafter all, as Rua came in to the cage and showed the rest of the light-heavyweight division how to effectively strike with Machida.Even the keyboard warriors are in a confused state. Many of the "this is the Machida Era" hype-riders are some of the same people who are crying acrossInternet blogs, calling for Cecil Peoples head, even though there were two other judges that scored the bout the same.Many forums have statements that Machida is a coward who ran away, and he should hand over his belt to Rua. There has even been the boxing legend of paid-off judges to keep the hype rolling.It's just really sad that a fan can't stick with their "favorite fighters" regardless of the outcome. This writer is a huge Lyoto Machida fan that feels his guy lost this fight in a very close decision that could of gone either way, but he is still backing his fighter 100 percent. It would be nice to see some of the so called "fans" act in the same manner.Oh well, even though the sport has come along way from it's "cockfighting" days, it seems that some of the fans still need to learn how to evolve from the wishy-washy knucklehead status that they unknowingly place on themselves.. Stocks The Toronto Stock Exchange's S&P/TSX composite index.GSPTSE rose 87.44 points, or 1.03 percent, to 8,592.37.Eight of the TSX's 10 sectors were higher.

(Reporting by Frank Pingue; editing by Peter Galloway) Stocks. Yesterday, during the Vikings-Steelers game, back judge Richard Reels was bulldozed by the Vikings Jeff Dugan on a kickoff return. Reels was hit so hard that he had to be attended to by the medical staff. He did eventually walk off on his own.But nontheless, the NFL is considering requiring officials to wear helmets.If NFL officials had the fancy footwork of this soccer referee, they wouldnt have to wear helmets. I have never seen such incredible backwards running skills in my life....click here to see video. "With Gartner forecasting globalMobile Advertising to surpass $12 billion by 2011, it is positioned to bethe next 'killer app' and MyScreen is the most effective deliveryplatform for advertisers and operators, with the best user experience forSubscribers.

Sentaca will help our Media & Mobile Carrier partners todeploy and scale quickly, maximizing the advertising and rewardsopportunities." After extensive research, MyScreen has selected Sentaca as their design,deployment and integration partner. The decision was based on designinnovation and experience, including Sentaca's extensive knowledge indelivering high-performance and scalable solutions to leading globaloperators; such as Vodafone, O2, T-Mobile, & AT&T."Sentaca is delighted to have the opportunity to partner with MyScreenand support the evolution and delivery of MyScreen's Mobile Advertisingsolution. MyScreen has designed a compelling solution and a uniqueapproach to the Mobile Advertising space and with Sentaca's globalexperience of delivering and integrating wireless applications to mobilecarriers, the relationship is truly complementary. Sentaca is lookingforward to a long and successful relationship with MyScreen Mobile,"stated Phil O'Neill, Chief Commercial Officer, Sentaca.About Sentaca:Sentaca is global leader in providing services and solutions to theTelecommunications industry. Sentaca isan Irish company with offices in the USA, Canada, UK and Poland.About MyScreen:Based in Toronto, Canada, MyScreen (PINK SHEETS: MYSL)(FRANKFURT: WICI)has revolutionized the way advertisers communicate with consumers.MyScreen is a patent-pending innovative marketing and advertisingsolution within the mobile communication industry, which has establishedboth a permission and incentive-based marketing model that allows mobilesubscribers to be compensated for allowing targeted rich-full screen,contextual advertisements to appear on their mobile device at the end ofa call.This press release contains "forward looking" statements within themeaning of Section 21A of the Securities Act of 1933, as amended, andSection 21E of the Securities Exchange Act of 1934 as amended. Suchstatements involve certain risks and uncertainties associated with anemerging company.

Actual results could differ materially from thoseprojected in the forward-looking statements as a result of risks andother uncertainties affecting the company, including those discussed inMyScreen Mobile reports and other documents filed with the U.S.Securities and Exchange Commission.Contacts:MyScreen Mobile Inc.Christine BarisheffVP, Communications(416) 413-9800 x 224Email: SentacaTim O'Donnell44 7515 973847Website: 2009, Market Wire, All rights reserved.-0-. DUBLIN, Ireland(Business Wire)Research and Markets( http://) hasannounced the addition of the "Enhancing Diabetic Care through IntelligentMedical Devices (Q4 08)" report to their offering. This executive update examines technologies used for monitoring diabeticpatients in the home, analyzes major product and service categories, andprofiles key industry players. "Technology vendors and service providersare investigating innovative ways to help a diabetic manage the diseaseproactively and holistically, from diet and lifestyle changes to weight andglucose monitoring to insulin delivery." Key Topics Covered: Notes on Methodology Diabetes Diagnosis and Prevalence Diabetes Management Technology Diabetes Service Providers and Care Models Forecasts Implications and RecommendationsCompanies Mentioned: Abbott Laboratories (MediSense and Therasense) AiMedics Pty Ltd. Bayer HealthCare, Diabetes Care Biosign Technologies Inc Body Media Inc BodyTel, Inc Cardiocom DexCom Inc. Diabetech, LP Eyesense GmbH Infopia USA Integrity Applications Johnson & Johnson (Animas Corporation and LifeScan) Medtronic Roche Solianis Holding AG US Diagnostics, Inc.